Has entered into a licensing agreement with Auris Health, Inc., a Johnson & Johnson MedTech company, in respect of certain intellectual property of Titan. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan’s IP. Titan Medical Inc. shares T.TMD are trading down $0.03 at $0.16.
Stocks in play: Titan Medical Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here